CoChat

Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis

Open access
Gudd, Cathrin L.C., Au, Lewis, Triantafyllou, Evangelos, Shum, Benjamin, Liu, Tong, Nathwani, Rooshi, Kumar, Naveenta, Mukherjee, Sujit, Dhar, Ameet, Woollard, Kevin J., Yone, You, Pinato, David J., Thursz, Mark R., Goldin, Robert D., Gore, Martin E., Larkin, James, Khamri, Wafa, Antoniades, Charalambos G., Turajlic, Samra, Possamai, Lucia A. · 2021 · Journal of Hepatology
Cited by 64

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Background & Aims Checkpoint inhibitor-related hepatitis (CPI-Hep) is an emerging clinical challenge. We aimed to gain insights into the immunopathology of CPI-Hep by comprehensively characterising myeloid and lymphoid subsets. Methods CPI-treated patients with or without related hepatitis (CPI-Hep; n = 22 and CPI-noHep; n = 7) were recruited. Phenotypic and transcriptional profiling of peripheral immune subsets was performed and compared with 19 healthy controls (HCs). In vitro monocyte-derived macrophages (MoMFs) were assessed for activation and cytokine production. CD163, CCR2, CD68, CD3, CD8 and granzyme B expression was assessed using immunohistochemistry/immunofluorescence (n = 4). Results A significant total monocyte depletion was observed in CPI-Hep compared with HCs ( p = 0.04), along with a proportionate increase in the classical monocyte population ( p = 0.0002) and significant upregulation of CCR2, CD163 and downregulation of CCR7. Soluble CD163 levels were significantly elevated in CPI-Hep compared with HCs ( p <0.0001). In vitro MoMFs from CPI-Hep showed enhanced production of pro-inflammatory cytokines. CD8 + T cells demonstrated increased perforin, granzyme B, ICOS and HLA-DR expression in CPI-Hep. Transcriptional profiling indicated the presence of activated monocyte and enhanced effector CD8 + T cell populations in CPI-Hep. Immunohistochemistry demonstrated co-localisation of CD8 + /granzyme B + T cells with CD68 + CCR2 + /CD68 + CD163 + macrophages in CPI-Hep liver tissue. Conclusions CPI-Hep is associated with activation of peripheral monocytes and an enhanced cytotoxic, effector CD8 + T cell phenotype. These changes were reflected by liver inflammation composed of CD163 + /CCR2 + macrophages and CD8 + T cells. Lay summary Some patients who receive immunotherapy for cancer develop liver inflammation, which requires cessation of cancer treatment. Herein, we describe ways in which the white blood cells of patients who develop liver inflammation differ from those of patients who receive the same immunotherapy but do not experience liver-related side effects. Targeting some of the pathways we identify may help to prevent or manage this side effect and facilitate cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2021.02.008

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 64

Metadata

Authors
Gudd, C. L. C., Au, L., Triantafyllou, E., Shum, B., Liu, T., Nathwani, R., Kumar, N., Mukherjee, S., Dhar, A., Woollard, K. J., Yone, Y., Pinato, D. J., Thursz, M. R., Goldin, R. D., Gore, M. E., Larkin, J., Khamri, W., Antoniades, C. G., Turajlic, S., & Possamai, L. A.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2021-07
Volume
75
Issue
1
Pages
177-189
ISSN
0168-8278 (ISSN-L)
OpenAlex
W3129833353
Cited by
64
References
18
FWCI
3.67
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.